MedTrace Logo

Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System

NCT07225478 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-01-08

No results posted yet for this study

Summary

The goal of this clinical study is to evaluate how well a new in-office whitening system works to whiten teeth compared to some other commercially available in-office whitening systems.

Conditions

  • Health Adult Subjects

Interventions

DRUG

Beaming White

25%HP gel for in office use only

COMBINATION_PRODUCT

Philips Zoom Professional Whitening Treatment

Light-Activated Whitening - Contains 25% HP gel for in-office use only

COMBINATION_PRODUCT

Opalescence Boost PF

Contains 40%HP whitening gel for in-office use only

DRUG

Fluoride Toothpaste

Colgate Cavity Protection Toothpaste

DEVICE

Soft Manual Toothbrush

Colgate Adult Extra Clean soft-bristle toothbrush

DEVICE

CP LED

CP LED 20mA

DEVICE

Gingival Barrier

Gingival Barrier

Sponsors & Collaborators

  • Colgate Palmolive

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2025-12-21
Completion
2025-12-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07225478 on ClinicalTrials.gov